Afs Financial Group, LLC Bristol Myers Squibb CO Transaction History

Afs Financial Group, LLC

  • $1.15 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 13, 2023
BUY
$57.89 - $64.73 $17,367 - $19,419
300 Added 5.25%
6,016 $349 Million
Q1 2023

Apr 20, 2023
SELL
$65.71 - $74.53 $6,570 - $7,453
-100 Reduced 1.72%
5,716 $396 Million
Q4 2022

Jan 25, 2023
BUY
$68.48 - $81.09 $398,279 - $471,619
5,816 New
5,816 $418 Million

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Afs Financial Group, LLC Portfolio

Follow Afs Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Afs Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Afs Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email